Back to Best of AC2017 Session: New Drugs 2016 - On-Demand
Best of AC2017 Session: New Drugs 2016 - On-Demand

Best of AC2017 Session: New Drugs 2016 - On-Demand

This session will provide an overview of all hematology/oncology drugs newly approved by FDA in 2016, plus expanded indications of existing drugs. Attendees will be able to identify appropriate use, key toxicities, and appropriate management of such toxicities.

 

Content Area: Patient Management & Therapeutics

Product Details

This session is from the HOPA 2017 Annual Conference

Speaker: Vivian Park, PharmD MBA BCOP

Learning Objectives:

1.      Describe the mechanisms of action of hematology/oncology drugs approved by the U.S. Food and Drug Administration (FDA) in 2016.

2.      Summarize key data supporting approval and the purported clinical benefits of these drugs.

3.      Identify common adverse events and appropriate prevention or management of such events.

 

  • List Price: $35.00 USD
  • Member Price: $25.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $10.00 USD or more!
Become a member